RxDoctor Payments Data

Jerry Markar

Anesthesiology · Los Angeles, CANPI 1083145320

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,941 of the $4,569 with a category attached, or 64.4%. Boston Scientific accounts for 72.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $2,396 and has fallen 99.1% since, to $22 in 2025. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,569in general payments, 2019–2025

Across 50 payments — averaging $91.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Nalu Medical, Inc.$374
  • Painteq LLC$257
  • Nevro Corp.$159
  • Medtronic$100
  • Johnson & Johnson$69
  • plus $278 from 9 others

What the payments were for

  • Travel & lodging$1,61335%
  • Food & beverage$2,94164%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,569 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California →

Medicare billing

Part B allowed, 2024
$131,357
Medicare patients
262
Services billed
1,166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine27$3,890
Pregabalin154$3,294
Gabapentin238$2,426
Lidocaine19$2,296
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen99$2,029
Duloxetine Hcl38$1,071
Naloxone Hcl15$869
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen51$606
Buprenorphine Hcl47$407
Diclofenac Sodium15$399
Tizanidine Hcl34$394
Methocarbamol52$375
Tramadol Hcl46$302
Oxycodone Hcl20$144
Morphine Sulfate11$68

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →